Inspire Medical Systems (INSP) Stock Analysis & Winston Score

Inspire Medical Systems makes a small implantable device that treats sleep apnea — a condition where people stop breathing repeatedly during sleep. The device, called the Inspire system, is surgically placed inside the chest and uses mild electrical signals to keep the airway open while a patient sleeps. It is sold to hospitals and surgical centers, and is used by patients who cannot tolerate the more common CPAP mask treatment. The company earns revenue by selling the Inspire implant and related components to healthcare providers, with each procedure generating a one-time device sale. Inspire operates primarily in the United States, with a growing presence in Europe, and has built a strong position as the only FDA-approved hypoglossal nerve stimulation device for sleep apnea on the market. Its main growth driver is expanding the number of trained surgeons and covered insurance plans, while its key risk is its dependence on a single product in a market that larger medical device companies could eventually enter.